AddLife AB

Equities

ALIF B

SE0014401378

Biotechnology & Medical Research

Market Closed - Nasdaq Stockholm Other stock markets 11:29:54 2024-04-26 am EDT			5-day change	1st Jan Change
98.65 ^SEK	+2.02%		+0.46%	-9.83%

Apr. 24	Transcript : AddLife AB, Q1 2024 Earnings Call, Apr 24, 2024
Apr. 24	AddLife AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Tranche Update on AddLife AB (OM:ALIF B)'s Equity Buyback Plan announced on October 28, 2022.

July 14, 2023 at 01:45 am EDT

From January 1, 2023 to May 4, 2023, the company has repurchased 0 shares, representing 0% for SEK 0 million. With this, the company has completed the repurchase of 110,000 shares, representing 0.09% for SEK 11.45 million under the buyback announced on October 28, 2022.

Latest news about AddLife AB

Transcript : AddLife AB, Q1 2024 Earnings Call, Apr 24, 2024	Apr. 24
AddLife AB Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 24	CI
Nordic Shares Rose Monday; FastPartner Series A Topped Leaders	Feb. 12	DJ
Transcript : AddLife AB, 2023 Earnings Call, Feb 02, 2024	Feb. 02
Addlife AB Proposes Dividend for the Year Ended December 31, 2023	Feb. 02	CI
AddLife AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 02	CI
AddLife to Start Trade Union Negotiations for Planned Shutdown of Camanio Operations	Jan. 08	MT
Nordic Shares Rose Wednesday; Hagar Hf. Topped Leaders	Dec. 20	DJ
Nordic Stocks Dropped Monday; Saab AB Series B Fell Furthest	Nov. 27	DJ
Transcript : AddLife AB, Nine Months 2023 Earnings Call, Oct 26, 2023	23-10-26
AddLife AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-26	CI
Transcript : AddLife AB - Analyst/Investor Day	23-09-15
Nordic Stocks Decreased Monday; Bakkafrost Posted Biggest Loss	23-07-17	DJ
Transcript : AddLife AB, H1 2023 Earnings Call, Jul 14, 2023	23-07-14
Tranche Update on AddLife AB (OM:ALIF B)'s Equity Buyback Plan announced on October 28, 2022.	23-07-14	CI
AddLife AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-14	CI
MGI and AddLife AB Announce Strategic Collaboration for Expanded Distribution of MGI products in the Nordic Region	23-06-08	CI
Addlife AB Declares Dividend	23-05-04	CI
AddLife AB's Equity Buyback announced on October 28, 2022, has expired with 110,000 shares, representing 0.09% for SEK 11.45 million.	23-05-03	CI
Transcript : AddLife AB, Q1 2023 Earnings Call, Apr 26, 2023	23-04-26
AddLife AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26	CI
Transcript : AddLife AB, 2022 Earnings Call, Feb 02, 2023	23-02-02
AddLife AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-02-02	CI
Tranche Update on AddLife AB (OM:ALIF B)'s Equity Buyback Plan announced on October 28, 2022.	23-02-02	CI
AddLife AB Proposes Dividend for the Year Ended December 31, 2022	23-02-02	CI

Chart AddLife AB

Duration

Period

More charts

Company Profile

AddLife AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The Company operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The Company operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.

Sector

Biotechnology & Medical Research

Calendar

2024-05-08 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for AddLife AB

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

98.65 SEK

Average target price

137 SEK

Spread / Average Target

+38.87%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
ADDLIFE AB	-9.83%	1.1B
IQVIA HOLDINGS INC.	+1.51%	42.75B
LONZA GROUP AG	+49.22%	41.61B
MODERNA, INC.	+8.57%	41.34B
CELLTRION, INC.	-12.36%	26.59B
ICON PUBLIC LIMITED COMPANY	+8.92%	25.49B
ALNYLAM PHARMACEUTICALS, INC.	-25.13%	18.12B
MEDPACE HOLDINGS, INC.	+29.17%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.12%	11.76B
UNITED THERAPEUTICS CORPORATION	+6.35%	11B

Other Biotechnology & Medical Research